The influence of heated heliox-driven nebulizer therapy on pulmonary hypertension and arterial oxygenation of patients with bronchial asthma

H. Loshkareva, S. Grigoriev, O. Aleksandrov (Moscow, Russian Federation)

Source: Annual Congress 2011 - Asthma: control and treatment
Session: Asthma: control and treatment
Session type: Thematic Poster Session
Number: 884
Disease area: Airway diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Loshkareva, S. Grigoriev, O. Aleksandrov (Moscow, Russian Federation). The influence of heated heliox-driven nebulizer therapy on pulmonary hypertension and arterial oxygenation of patients with bronchial asthma. Eur Respir J 2011; 38: Suppl. 55, 884

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Selection of the optimal nebulizer for further clinical development of inhaled nebulized nitrite (AIR001) in pulmonary arterial hypertension patients
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Effects of nebulised iloprost on pulmonary function and oxygenation in patients with severe pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 370s
Year: 2002

Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension
Source: Eur Respir J 2001; 17: 14-19
Year: 2001



Effects of inhaled salbutamol in primary pulmonary hypertension
Source: Eur Respir J 2002; 20: 524-528
Year: 2002



Effects of long-acting inhaled β-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with COPD
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006


Influence of heliox upon pulmonary haemodynemics in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 238s
Year: 2001

Experience with inhaled iloprost in paediatric pulmonary arterial hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011


Effects of continuous positive airway pressure (nCPAP) on pulmonary hemodynamics in COPD patients with overlap syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 568s
Year: 2004

Oral sildenafil is a potent pulmonary vasodilator and improves gas exchange in patients with COPD with pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 426s
Year: 2006

Influence of inhaled iloprost on transpulmonary gradient of big-endothelin in patients with pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 25s
Year: 2002

Acute response of iloprost inhalation using the Breelib nebulizer in pulmonary arterial hypertension: the Breelib acute study
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Effect of salbutamol on arterial blood gas tensions in patients with stable hypercapnic chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 16s
Year: 2004

Biphasic cuirass ventilation decreased the indices of pulmonary circulation in patients with secondary pulmonary hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011

Effect of NPPV on pulmonary arterial hypertension in patients with hypercapnic respiratory failure
Source: Annual Congress 2007 - Acute respiratory failure and noninvasive mechanical ventilation
Year: 2007


Use of heated heliox-driven nebulizer therapy in the treatment of patients with bronchial asthma
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009


Pulmonary hypertension at the patients with bronchial asthma and COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 58s
Year: 2004

Long-term improvement of pulmonary haemodynamics and exercise capacity in patients with pulmonary hypertension and hypoventilation following NIPPV and influence of NIPPV adherence
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015

Inhaled treprostinil therapy in patients with pulmonary hypertension and parenchymal lung disease
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011

Systemic inflammation and pulmonary hypertension in patients with bronchial asthma
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008

Influence of natural lung surfactant inhalations on clinical symptoms and pulmonary function parameters in patients with bronchial asthma
Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Year: 2018